Skip to main navigation
Top Nav
Contact
SEARCH
About Us
Our Scientific Heritage
Aerie At-a-Glance
Our Leadership
Our Board of Directors
Our ESG Commitment
Products
Rhopressa
®
Rocklatan
™
R&D
Pipeline
AR-13503 Implant
AR-1105 Implant
Drug Delivery
Clinical Trials
Research Bibliography
Investigator Initiated Research
For Eye Care Professionals
Our VISION
aerie
™
Legacy
Aqueous Humor Dynamics
Trabecular Meshwork
ROCK Inhibition
Medical Affairs
Investors
FAQs
News & Presentations
News Releases
Events & Presentations
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Reports & Filings
SEC Filings
Annual Reports & Proxies
Quarterly Results
Corporate Governance
Compliance
Committee Composition
Contact the Board
Our ESG Commitment
Our Leadership
Our Board of Directors
Contact Us
Sign up for email alerts
Careers
Working at Aerie
Investors
Aerie Pharmaceuticals, Inc. Second Quarter 2015 Earnings Call
Aug 5, 2015 at 5:00 PM EDT
